Galmed Pharmaceuticals Announces Successful Clinical Study Results For Subsidiary Colospan

Filing content

Galmed Pharmaceuticals' subsidiary, Colospan, announced the successful completion of a feasibility study for its novel intraoperative tissue assessment technology.